Blocking TLR4 can improve the insulin-dependent intake of glucose and alleviate insulin resistance induced by HFD in mice, which may be because the knockout of TLR4 leads to a decrease in inflammatory factors. The gene discussed is INS; the disease is Insulin resistance.